
Exelixis
Data breach claim reported November 17, 2026
| Data Breach Report | |||
|---|---|---|---|
| Victim | exelixis.com | ||
| Claimed By | n0n | ||
| Date Discovered | Nov 17, 2026 | ||
| Description | Exelixis, Inc. is a biopharmaceutical company based in USA (California), discovering, developing, and commercializing cancer therapies, including its cabozantinib-based medicines. | ||
| Leak Size | Unknown |
Breach claims on this page are published by threat actors and haven't been verified by Breachsense.
Credential Exposure for exelixis.com
We've indexed 411 @exelixis.com accounts from external breaches, plus 5 credentials for exelixis.com itself.
Last checked Nov 17, 2026
| @exelixis.com addresses from external breaches | |
|---|---|
| Third-party breaches | 401 accounts · across 81 breaches · 381 with a plaintext password · most recent Oct 5, 2025 |
| Combo lists | 118 accounts · most recent Nov 12, 2026 |
| Passwords for exelixis.com accounts | |
|---|---|
| Combo lists | 4 logins · most recent Nov 11, 2026 |
| Infostealer logs | 1 logins · most recent Jan 1, 2022 |
Logins may belong to customers or to staff, and the data doesn't say which. None of this is necessarily connected to the ransomware attack above.
Is your organization next?
Check if your company's credentials have been exposed in this or other data breaches.
Continuous dark web monitoring alerts you when we find leaked credentials or session tokens for your company.